Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Abercrombie & Fitch Co. Stock Skyrocket on Killer Q3

By William White, InvestorPlace Writer
Abercrombie & Fitch (ANF) stock was skyrocketing on Friday following a stellar earnings report for the third quarter of the year.

Pallid Industry Group Rank Penalize Exxon Mobil (XOM) Rating

By Portfolio Grader
The current recommendation of Hold for Exxon Mobil Corp (NYSE:XOM) has been derived by using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Blue Apron Holdings Inc Stock Is on Its Way to the Bottom

By Ian Bezek, InvestorPlace Contributor
Short sellers are hounding APRN stock and sentiment is universally negative. Will it be enough to finally power a rally for one of the year's worst IPOs?

Johnson & Johnson’s (JNJ) Healthy Quant Score Keep it a Buy

By Portfolio Grader
Johnson & Johnson Co (NYSE:JNJ) is ranked as a Buy using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking JNJ has had from Portfolio Grader for 8 months.

Why It’s Time to Put Pfizer Inc. Stock on Your Watchlist

By James Brumley, InvestorPlace Feature Writer
Pfizer may not be a great company now, but it may be a great company again soon. Time to put PFE stock on your watchlist.

Why Investors Should Hold Off on Buying BP plc (ADR) Stock

By Will Healy, InvestorPlace Contributor
The BP stock price is up as it sees higher crude prices and lower fines, but BP stock needs a lower dividend and higher natural gas prices.

There Are No Guarantees for Amazon.com, Inc. Stock

By Dana Blankenhorn, InvestorPlace Contributor
No company is perfect, not even Amazon.com. Investors need to remember that as AMZN stock rises to new heights.

Facebook Inc Stock Can Still Deliver Value, Even at These Levels

By Josh Enomoto, InvestorPlace Contributor
Although the FB stock price is rapidly approaching the $200 level, investors will find confidence in its dominant fundamentals.

Williams-Sonoma, Inc. (WSM) Dips on in-Line Profit, Buys Outward, Inc.

By Karl Utermohlen, InvestorPlace Writer
Williams-Sonoma (WSM) posted third-quarter earnings that met expectations after hours, while also announcing the acquisition of Outward, Inc.

Splunk Inc (SPLK) Shares Skyrockets on 34% Revenue Increase

By Karl Utermohlen, InvestorPlace Writer
Splunk (SPLK) had a strong quarter that sent its stock rising more than 10% after hours, with revenue surging 34% compared to the year-ago.

Ross Stores, Inc. (ROST) Shares Soar on Profit Beat

By Karl Utermohlen, InvestorPlace Writer
Ross Stores (ROST) posted its third-quarter results after hours Thursday, coming in ahead of the earnings and revenue estimate, per Zacks.

Gap Inc (GPS) Comps Rise 3% Year-Over-Year

By Karl Utermohlen, InvestorPlace Writer
Gap (GPS) posted its third-quarter results after hours Thursday, unveiling revenue and comparable sales that were ahead of last year's mark.

Steven Cohen’s 6 Best Performing Stocks That Still Have Big Upside

By Matt Hogan, Founder, Finbox.io
If you haven't heard of Billionaire Steven Cohen, you may already know a little about him if you've watched Showtime's hit series "Billions." Damian Lewis plays…

Applied Materials, Inc. (AMAT) Shares Slip Despite 41% EPS Growth

By Karl Utermohlen, InvestorPlace Writer
Applied Materials (AMAT) unveiled its latest quarterly earnings results soon after the bell and its earnings gained about 41% year-over-year.

Evolent Health (EVH) a Sell on Sagging Earnings Momentum

By Portfolio Grader
Evolent Health Inc (NYSE:EVH) is a component of the 24 company Health Care Technology GICS industry group, which is a segment of the 782 company GICS Health Care sector. EVH has a market value of $0.8 billion which is in the top half of its industry group. The current Portfolio Grader ranking for EVH puts it 23 among the 24 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 688 among the 782 companies in the sector, and number 4,187 in the nearly 5,000 company Portfolio Grader universe.

HMS Holdings (HMSY) Dropped to Strong Sell on Adverse Earnings Momentum

By Portfolio Grader
HMS Holdings Corp (NASDAQ:HMSY) is one of 24 companies within the Health Care Technology GICS industry group, which is in turn part of the 782 company GICS Health Care sector. HMSY's market value is $1.3 billion which falls in the upper half of its industry group. The current Portfolio Grader ranking for HMSY puts it 24 among the 24 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 708 among the 782 companies in the sector, and number 4,269 in the nearly 5,000 company Portfolio Grader universe.

Earnings Growth Make Omnicell (OMCL) a Buy

By Portfolio Grader
Omnicell Inc (NASDAQ:OMCL) is one of the 782 companies in the GICS Health Care sector, and a constituent of the 24 company Health Care Technology GICS industry group within this sector. OMCL has a market value of $1.8 billion which is in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 3 among the 24 companies in this industry group, placing it among the leaders; among the sector leaders with a ranking of 72 among the 782 companies in the sector, and number 489 in the nearly 5,000 company Portfolio Grader universe.

Anemic Sales Growth Hurt Inovalon Holding (INOV) Rating

By Portfolio Grader
Portfolio Grader currently ranks Inovalon Holding Inc (NASDAQ:INOV) a Hold. Using Louis Navellier's investing approach, this analytical tool researches stocks by means of fundamental and quantitative metrics. INOV has maintained this ranking for 3 months.

Falling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader
Currently, Allscripts Healthcare Solutions (NASDAQ:MDRX) has a Sell using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MDRX has had from Portfolio Grader for 3 months.
Load More Articles